文献速递外周动脉疾病

全国代表性样本中间歇性跛行与严重肢体缺血患者的再入院因素

Nationally Representative Readmission Factors in Patients with Claudication and Critical Limb Ischemia.
PubMed 文献 · Ann Vasc Surg · 2018-05-17

基于全国再入院数据库(NRD)纳入92769例因外周血管疾病入院并接受血运重建的患者(间歇性跛行33055例,严重肢体缺血59714例),分析30天及总体再入院率、费用、住院时长与死亡。结果显示严重肢体缺血患者再入院率、费用与死亡率均高于间歇性跛行患者,并发现多个再入院预测因素。

要点

  • 间歇性跛行与严重肢体缺血的30天再入院率分别为8.97%和19.26%,总体再入院率分别为21.49%和40.36%。
  • 严重肢体缺血患者初始住院费用、再入院费用、住院时长及死亡率均高于间歇性跛行患者。
  • 间歇性跛行、严重肢体缺血、血管腔内成形术、外周旁路术、主股旁路术、女性、年龄>65岁、Charlson合并症指数、住院时长及主要预期付款方状态是再入院的显著预测因素。

核心结论

  • 因间歇性跛行与严重肢体缺血入院的患者在再入院率、费用和发病率方面存在显著差异。
  • 回归分析显示多个其他明确危险因素与较差的临床和经济结局相关。
  • 需要进一步研究以预测哪些患者住院期间需要加强警惕以预防再入院和更差结局。

研究设计与样本

  • 研究使用全国再入院数据库(NRD),该数据库收集来自22个地理分散州的出院信息,覆盖美国常住人口的51.2%和全美住院的49.3%。
  • 纳入因间歇性跛行(ICD-9 440.21)或严重肢体缺血(ICD-9 440.22-440.24)入院并接受经皮腔内血管成形术、外周旁路术或主股旁路术的所有患者。
  • 共92769例患者因外周血管疾病入院,其中间歇性跛行33055例,严重肢体缺血59714例。
  • 对间歇性跛行和严重肢体缺血组的所有关注结局进行单变量和多变量逻辑回归分析。
  • 证据等级:护理管理/流行病学,level IV。

主要发现

  • 间歇性跛行与严重肢体缺血的30天再入院率分别为8.97%和19.26%,总体再入院率分别为21.49%和40.36%。
  • 间歇性跛行与严重肢体缺血的初始住院费用分别为18548美元和29148美元(P < 0.001),再入院费用分别为14726美元和17681美元(P < 0.001)。
  • 间歇性跛行与严重肢体缺血的住院时长分别为4天和9天(P < 0.001),再入院时间分别为73天和59天(P < 0.001)。
  • 间歇性跛行与严重肢体缺血的初始住院期间死亡分别为256例和1363例(P < 0.001),任何住院期间死亡分别为538例和3838例(P < 0.001)。
  • 最常见的5个再入院疾病组为其他血管操作(12.6%)、下肢截肢(除外趾)(6.3%)、脓毒症(5.4%)、心力衰竭(4.9%)和术后或其他装置感染(4.8%)。

关键数值与推荐

  • 单变量和多变量逻辑回归分析发现,间歇性跛行、严重肢体缺血、血管成形术、外周旁路术、主股旁路术、女性、年龄>65岁、Charlson合并症指数、住院时长和主要预期付款方状态均为30天和总体再入院的显著预测因素,程度不一。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Hospital readmissions are associated not only with increased mortality, morbidity, and costs but also, with current health-care reform, tied to significant financial and administrative penalties. Some studies show that patients undergoing vascular surgery may have higher than average readmission rates. The recently released Nationwide Readmission Database (NRD) is the most comprehensive national source of readmission data, gathering discharge information from 22 geographically dispersed states, accounting for 51.2% of the total U.S. resident population and 49.3% of all U.S. hospitalizations. The aim of this study is to use the power of the NRD and obtain nationally representative readmission information for patients admitted with claudication or critical limb ischemia (CLI) who underwent revascularization procedures. METHODS: The NRD was queried for all patients admitted for claudication (International Classification of Diseases Ninth Revision [ICD-9] 440.21) or CLI (ICD-9 440.22-440.24) and who underwent percutaneous transluminal angioplasty, peripheral bypass, or aortofemoral bypass. Patient demographics, comorbidities, length of stay (LOS), mortality, readmission rates, and associated costs were collected. Univariable and multivariable logistic regression analysis was implemented on claudication and CLI groups on all outcomes of interest. The most common readmission diagnosis codes and diagnosis groups were also identified. RESULTS: A total of 92,769 patients were admitted for peripheral vascular disease (33,055 with claudication and 59,714 with CLI). The 30-day readmission/any readmission rate was 8.97%/21.49% and 19.26%/40.36%, for claudication and CLI, respectively. Significant differences were found for claudication and CLI, respectively, on initial cost of admission ($18,548 vs. $29,148, P < 0.001), readmission costs ($14,726 vs. $17,681 P < 0.001), LOS (4 days vs. 9 days, P < 0.001), days to readmission (73 days vs. 59 days, P < 0.001), mortality during initial admission (256 vs. 1,363, P < 0.001), and mortality during any admission (538 vs. 3,838, P < 0.001). Univariate and multivariate logistic regression analysis found that claudication, CLI, angioplasty, peripheral bypass, aortofemoral bypass, female sex, age >65, Charlson Comorbidity Index, LOS, and primary expected payer status were all significant predictors of 30-day and overall readmissions at varying degrees. The 5 most common disease readmission groups found were other vascular procedures (12.6%), amputation of lower limb except toes (6.3%), sepsis (5.4%), heart failure (4.9%) and postoperative or other device infections (4.8%). Of the abovementioned groups, the 4 most common diagnoses included "other postoperative infections," sepsis, atherosclerosis of native arteries with gangrene, and "other complications due to other vascular device, implant, or graft." CONCLUSIONS: Our results demonstrate that there is a significant difference in readmission rates, cost, and morbidity between patients admitted for claudication and CLI. Furthermore, based on regression analysis, there are multiple other clear risk factors associated with worse clinical and economic outcomes. Further study is needed to predict which patients will require increased vigilance during their hospital stay to prevent readmissions and worse outcomes. LEVEL OF EVIDENCE: Care management/epidemiological, level IV.

来源:Ann Vasc Surg,查看原文。版权归原作者所有。

引用

  1. Martinez RA, Shnayder M, Parreco J, et al. Nationally Representative Readmission Factors in Patients with Claudication and Critical Limb Ischemia. Ann Vasc Surg. 2018. PMID: 29777842. doi:10.1016/j.avsg.2018.03.011

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。